James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer | Official Website
James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer | Official Website
This is unchanged from the number of companies cited in the previous quarter.
The citations in the county include:
- Management with executive responsibility has not reviewed the suitability and effectiveness of the quality system.
- Quality audits have not been performed.
- Risk analysis is inadequate.
The company cited was involved in the Devices sector.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
R-Med, Inc. | Devices | 04/23/2025 | Management review - defined interval, sufficient frequency |
R-Med, Inc. | Devices | 04/23/2025 | Quality Audit/Reaudit - conducted |
R-Med, Inc. | Devices | 04/23/2025 | Design Validation - Risk analysis not performed/inadequate |
R-Med, Inc. | Devices | 04/23/2025 | Design history file |
R-Med, Inc. | Devices | 04/23/2025 | Lack of or inadequate procedures - Acceptance activities |
R-Med, Inc. | Devices | 04/23/2025 | Nonconforming product, Lack of or inadequate procedures |
R-Med, Inc. | Devices | 04/23/2025 | DMR - not or inadequately maintained |
R-Med, Inc. | Devices | 04/23/2025 | DHR - not or inadequately maintained |
R-Med, Inc. | Devices | 04/23/2025 | Complaints |
R-Med, Inc. | Devices | 04/23/2025 | Statistical techniques - Lack of or inadequate procedures |